Mark Miller
Chief Investor Relations Officer
Replay available
Encompass Health Corporation (NYSE: EHC) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
President and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Senior Vice President, Talent Acquisition
Analyst, Barclays
Analyst, KeyBank
Analyst, Deutsche Bank
Analyst, UBS
Analyst, Jefferies
Analyst, Mizuho Securities
Analyst, Stevens
Analyst, Bank of America
Please stand by, your program is about to begin. If you need assistance on today's conference, please press star zero. Good morning everyone, and welcome to Encompass Health's second quarter 2025 earnings conference call. At this time, I would like to inform all participants that their lines will be in a listen-only mode. After the speakers' remarks, there will be a question and answer session. If you would like to ask a question during this time, please press star one on your telephone keypad. You will be limited to one question and one follow-up question. Today's conference call is being recorded. If you have any objections, you may disconnect at this time. I will now turn the call over to Mark Miller, Encompass Health's Chief Investment Relations Officer. Thank you, operator, and good morning everyone. Thank you for joining Encompass Health's second quarter 2025 earnings call. Before we begin, if you do not already have a copy, the second quarter earnings release, supplemental information, and related form 8K filed with the SEC are available on our website at EncompassHealth.com. On page two of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt, and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations are discussed in the company's SEC filings, including the earnings release and related form 8K, the form 10K for th...